Free Newsletter
Feds probe Medtronic payments to docs
The feds are investigating payments Medtronic made to doctors, hospitals, and others that use its heart devices and stents. According to a filing with the Securities and Exchange Commission, a U.S. Attorney's Office in Pennsylvania has asked the company for details on both cash and in-kind payments. This particular U.S. Attorney, Patrick Meehan, has previously prosecuted healthcare fraud cases involving pharma companies and benefits managers.
Earlier this year, Sen. Charles Grassley asked for information on Medtronic's payments to orthopedic surgeons. Grassley has introduced a bill that would require device and drug makers to disclose payments they make to doctors.
The company has said it pays doctors for help developing new products and for training other doctors to use them. A spokeswoman wouldn't comment on this particular investigation.
- see Medtronic's SEC filing (information on this investigation is under Legal Proceedings)
- check out this report from the St. Paul Pioneer Press
Related Articles:
FDA panel: Approve Medtronic stent
Medtronic's doc payments draw new fire
Medtronic will settle accusations on kickbacks
Study: Drug coated stents may be safe
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: